Product News: Health, Medical, & Dental Supplies and Equipment

Oscillating Positive Expiratory Pressure Device offers expiratory flow bias.

Press Release Summary:

Oscillating Positive Expiratory Pressure Device offers expiratory flow bias.

Sep 29, 2017 -

iPEP® Oscillating Positive Expiratory Pressure Device is suitable for lung expansion, treatment of atelectasis, and secretion clearance. Unit comes with palm-sized PocketPEP® OPEP device which is used to prevent pulmonary-related readmissions. Product provides slow coached inhalation and biofeedback.

D R Burton Healthcare, LLC - Farmville, NC

Original Press Release

D R Burton Healthcare Launches the iPEP® - the Only Volume-Based Oscillating PEP Device

Press release date: Sep 28, 2017

D R Burton Healthcare Products LLC announces the launch of the iPEP® Oscillating Positive Expiratory Pressure (OPEP) device, which uniquely combines OPEP and Incentive Spirometer therapies to address all-three respiratory needs: lung expansion, treatment of atelectasis, and secretion clearance.

“The iPEP system represents a breakthrough in airway secretion clearance therapy by providing patented volumetric-based OPEP therapy. The iPEP takes the mystery out of OPEP therapy by providing patients and healthcare providers with biofeedback that measures the patient’s inspiratory capacity during therapy,” according to Dennis Cook, BSRT, RRT, CEO of D R Burton.

Along with a slow coached inhalation, the iPEP provides superior Expiratory Flow Bias, a key driver of secretion clearance outlined in a recently published study.

The iPEP system includes a palm-sized PocketPEP®, a compact OPEP device for active patients for use at home to help prevent pulmonary-related readmissions. Cook explains, “There is a need to prevent pneumonia in high risk patients, such as postoperative and patients with increased mucous production. The D R Burton family of OPEP products are designed to reduce the risk of not only hospital acquired pneumonia, but also reduce risk of pneumonia at home after discharge.”

D R Burton will be meeting with clinicians to discuss these products at the American Association of Respiratory Care Congress (AARC) on October 4-7 in Indianapolis, IN.

REFERENCE: Pursley, D.M., “Analysis of three Oscillating Positive Expiratory Pressure Devices During Simulated Breathing,” Respiratory Therapy 2017; Volume 12, No. 1, 52-56.

About D R Burton Healthcare Products LLC

D R Burton Healthcare Products LLC, innovators in medical devices, was founded by clinicians with deep expertise in respiratory care. Together we design, develop and market medical device products that allow patients to heal faster and provide value to our partners and consumers. Our unique clinical perspective drives our unwavering commitment to provide clinicians and their patients with a world class user experience. For more information, please visit http://www.drburtonhpi.com